Scientists Appeal Decision In Eli Lilly Patent Suit

Law360, New York (May 10, 2006, 12:00 AM EDT) -- Doctors that allege they co-discovered a gene used in Eli Lilly’s high-earning drug Xigris, appealed last Friday a decision by a judge in support of the giant pharmaceutical company.

Gerald Crabtree and his former research colleague Jorge Plutzky contend that they cloned a Protein C gene, and that Lilly that did not include their names when it filed a patent for the gene in order to avoid paying royalties.

Xigris, which is used to combat the blood infection sepsis, earned $215 million for Lilly last year....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.